G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/53 (2006.01)
Patent
CA 2622036
This invention relates generally to identifying peptide sequences involved in antibody binding to any protein for synthesis of vaccine treatments. This novel method allows for a more manageable vaccine peptide discovery and specific generation of unique immunogenic peptides from self-tumor associated proteins and/or foreign proteins from infectious organisms for specific and/or enhanced expression only in the presence of the antibody.
Cette invention porte, de manière générale, sur l'identification de séquences peptidiques intervenant dans la liaison d'anticorps à toute protéine dans la synthèse des thérapies vaccinales. Cette nouvelle méthode permet de rechercher des peptides vaccinaux plus gérables et une génération spécifique de peptides immunogènes uniques provenant d'autoprotéines associées à des tumeurs et/ou de protéines exogènes provenant d'organismes infectieux pour obtenir une expression spécifique et/ou améliorée uniquement en présence de l'anticorps.
Flora Michael
Peoples George E.
Ponniah Sathibalan
Storrer Catherine E.
Henry M. Jackson Foundation For The Advancement Of Military Medi In C.
Ledgley Law
LandOfFree
Targeted identification of immunogenic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted identification of immunogenic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted identification of immunogenic peptides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1695659